A Phase II Double-blind Randomised, Placebo-controlled Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Bronchiolitis
- Focus Therapeutic Use
- 10 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2017.
- 10 Oct 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 03 May 2016 Planned initiation date changed from 1 Jul 2015 to 1 Dec 2016.